Literature DB >> 371698

Chronic hypoplastic marrow failure and residual injury.

A A Morley, K J Trainor, R S Seshadri.   

Abstract

An experimental model of chronic marrow failure can be produced in mice by treatment with a short course of busulphan. This results in permanent partial marrow failure which may later progress and become complete. The underlying lesion appears to be stem cell damage which leads to failure of proliferation of stem cells and their progeny. Other drugs can produce the same lesion and alkylation of DNA may be the mechanism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 371698

Source DB:  PubMed          Journal:  Blood Cells        ISSN: 0340-4684


  6 in total

1.  Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse.

Authors:  John A Turton; William R Sones; Charles M Andrews; Andrew M Pilling; Thomas C Williams; Gemma Molyneux; Sian Rizzo; Edward C Gordon-Smith; Frances M Gibson
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

2.  Residual effects of busulfan and irradiation on murine hematopoietic stem and progenitor cells.

Authors:  Kaylind Batey; Jisoo Kim; Lauren Brinster; Gladys Gonzalez-Matias; Zhijie Wu; Sabrina Solorzano; Jichun Chen; Xingmin Feng; Neal S Young
Journal:  Exp Hematol       Date:  2021-11-08       Impact factor: 3.084

3.  Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms.

Authors:  P C Vincent
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

4.  A new model of busulphan-induced chronic bone marrow aplasia in the female BALB/c mouse.

Authors:  Frances M Gibson; C Michael Andrews; Paraskevi Diamanti; Sian Rizzo; George Macharia; Edward C Gordon-Smith; Thomas Williams; John Turton
Journal:  Int J Exp Pathol       Date:  2003-02       Impact factor: 1.925

5.  Serum FLT-3 ligand in a busulphan-induced model of chronic bone marrow hypoplasia in the female CD-1 mouse.

Authors:  Gemma Molyneux; Frances M Gibson; Matthew Whayman; John A Turton
Journal:  Int J Exp Pathol       Date:  2008-04       Impact factor: 1.925

Review 6.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.